Collection and banking of fresh tumours for frozen storage for patients undergoing planned excision of tumours

Not Applicable

Active, not recruiting

• Conditions: Solid tumours; Cancer - Any cancer

• Registration Number: ACTRN12615000476538
• Lead Sponsor: Regeneus Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Adults 18 years of age and over
- Planned surgery as routine treatment for cancer from which tumour can be sourced
- In the investigator's opinion, has a tumour of a size that is likely to yield at least 1 cm3

Exclusion Criteria

- Treatment for cancer in the 4 weeks prior to tumour excision surgery
- Current or past history of active autoimmune disease
- Known HIV infection
- Chronic hepatitis
- History of organ transplant or other condition requiring immunosuppressant medications
- Chronic systemic corticosteroid therapy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To obtain fresh tumour tissue during planned surgery in a safe & ethical manner for long term frozen storage. Participants will have signed informed consent prior to their routine surgery; a patient registration form will be completed prior to surgery to arrange logistics support; a tumour requisition form will be completed to document the sample traceability, tumour banking process and final location of the tumour in the repository. Participants are identified by a tumour bank ID / barcode to ensure confidentiality and privacy compliance. [Day of surgery / Day 1]

Secondary Outcome Measures

Name	Time	Method
one[N/A]